Two years on from The Royal Gazette’s first report on a new wave of diabetes drugs with broader health benefits, the island’s ...

Millions of Medicaid beneficiaries have limited access to Type 2 diabetes medications that reduce the risk of cardiovascular disease, according to a study published April 22 in Annals of Internal ...

As the diabetes and weight loss market booms, more collaboration between pharma and medtech could help patients get the most ...

A large population-based study found that GLP-1 receptor agonists (GLP-1RAs) and SGLT2 inhibitors (SGLT2is), two classes of ...

Older adults living with Type 2 diabetes face more than just blood sugar concerns. New research shows some of the most ...

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and ...

Blockbuster weight loss drug Ozempic can cause a surprising side effect in your feet - and some celebrities are already ...

The following chart lists examples ... In addition, the American Diabetes Association’s treatment guidelines recommend GLP-1 agonists (the drug class Ozempic and Victoza belong to) as a ...

In general medicine the frequency of with which the physicians reviewed medication charts on routine ward rounds ( Table 1) ranged from 45 to 100% (mean = 77 ± 16%). Between 6 and 15 patients ...

If you have diabetes or high blood sugar, you probably know some of the things that cause your glucose (another name for blood sugar) to go up. Like a meal with too many carbohydrates, or not ...